Updated Jul 16, 2026
Agarwal Arjun has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.29M.

Agarwal Arjun is a finance executive who, according to the most recent SEC filing dated 2026-03-17, serves as Senior Vice President, Finance at Oruka Therapeutics, Inc. This role places him as the senior finance leader responsible for the company's financial planning, reporting, and related governance functions. Beyond the information contained in the SEC filing, public sources do not provide a detailed career history, education, or personal background for this individual. There is no publicly disclosed net worth, and no widely available biographical profile confirming other positions, awards, or affiliations. The available SEC reference does not indicate death; however, there is no independent confirmation of this individual's full biographical details outside the filing. Name variations suggest the person could also be listed as Arjun Agarwal in other records. Based on SEC filings, there is limited public information beyond his current role.
| Role | Senior Vice President, Finance |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 300 | $85.63 | $26K |
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 5.7K | $84.90 | $480K |
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.7K | $84.26 | $315K |
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 300 | $83.07 | $25K |
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise [10b5-1] | 1.5K | $34.39 | $50K |
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise [10b5-1] | 8.5K | $12.50 | $107K |
| 2026-06-22 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 699 | $82.14 | $57K |
| 2026-06-22 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 888 | $80.01 | $71K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 395 | $69.69 | $28K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 3.3K | $70.34 | $229K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 4.3K | $69.85 | $303K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 1.9K | $68.34 | $127K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise | 1.5K | $34.39 | $50K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise | 8.0K | $12.50 | $100K |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 700 | $61.16 | $43K |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 800 | $60.34 | $48K |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 4.6K | $59.19 | $272K |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 4.2K | $58.34 | $244K |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise | 5.8K | $34.39 | $201K |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise | 2.0K | $12.50 | $25K |
Agarwal Arjun is a finance executive who, according to the most recent SEC filing dated 2026-03-17, serves as Senior Vice President, Finance at Oruka Therapeutics, Inc. This role places him as the senior finance leader responsible for the company's financial planning, reporting, and related governance functions. Beyond the information contained in the SEC filing, public sources…
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 15 open-market sales ($2.29M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Agarwal Arjun profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.